Skip to main content
OpenTrials
Completed

NCT Number: NCT07180017

A Survey of Turkish Pediatric Physical Therapists

CP encompasses a group of persistent disorders of movement and posture development resulting from injury to the developing brain. Thanks to preventive measures and advances in obstetric and neonatal care, the incidence and severity of CP are currently decreasing in some countries, and the use of early diagnosis guidelines or protocols in follow-up units highlights the potential for faster recovery. A 2017 clinical review of early diagnosis tools, published by a group of international experts with best practice recommendations, called for earlier diagnosis through timely use of recommended tools. The diagnosis of CP is typically made by a physician between 12 and 24 months of age, but in some cases, it is delayed until 42 months. Early identification of a high risk of CP relies on a combination of a detailed patient history, developmental assessment, a structured and validated neurological examination or neuromotor assessment, and brain imaging studies. Conversely, the accurate and early use of key tools for early diagnosis can allow for much earlier detection of CP in infants younger than or older than 5 months.According to international guidelines, infants at high risk of CP should be monitored. This monitoring should be conducted by an interdisciplinary team, including a neonatologist, pediatrician, pediatric neurologist, pediatric physiotherapist, speech-language-swallowing therapist, and special education specialist. Pediatric physiotherapists are a crucial part of this team for developmental follow-up and rehabilitation. Therefore, it is important that pediatric physiotherapists in our country have sufficient awareness in this field, are equipped with various training programs, and reach international standards. This allows them to provide early guidance to families at risk of CP, facilitate early diagnosis of CP, and initiate treatment.The aim of this study was to evaluate the use of early diagnostic assessment tools in pediatric physiotherapy practice in Turkey for infants aged 0-2 years at risk for cerebral palsy (CP). Best practice guidelines worldwide recommend the timely use of key assessment tools to reduce the age at which CP is diagnosed. In this context, a digital survey administered to pediatric physiotherapists in Spain, translated into Turkish with the necessary permissions, will be used to determine the awareness levels of physiotherapists in Turkey.

Completed

Looking for future studies?

Notify Me

Key information

Age range

25 year–50 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Kahramanmaraş Sütçü imam University

Kahramanmaraş, Onikişubat, 46100, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All literate pediatric physiotherapists between the ages of 25-50 working in different provinces in Turkey

Exclusion criteria

  • Physiotherapists with no experience in pediatric physiotherapy

Treatment and study plan

Primary outcomes

  1. Digital survey for pediatric physiotherapists(PTs)

    Time frame: DAY1

    A purpose-built digital survey consisting of 45 multiple-choice questions with five thematic sections. The survey used in this context will be a survey administered digitally to pediatric physiotherapists in Spain, translated into Turkish with the necessary permissions. This survey will be administered via Google Forms.

Secondary outcomes

  1. Demographic Information

    Time frame: DAY1

    Sosyodemographic information of PTs will be recorded.

Sponsors and collaborators

Lead sponsor

Kahramanmaras Sutcu Imam University

Other

Registry information

Official study title

Use of Tools for Early Detection of Cerebral Palsy: A Survey of Turkish Pediatric Physical Therapists

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Sep 18, 2025
Registry last updated
Sep 23, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.